Mergers & Acquisitions Contracts & Agreements in the Pharmaceuticals Industry

528 Contracts & Agreements

Browse by Subcategory

Joint Venture Agreements (37 contracts from 21 companies)
Merger Agreements (473 | 225)
Plan of Reorganization Agreements (18 | 14)

Browse by Company

4Front Ventures Corp. (5 contracts)
60 DEGREES PHARMACEUTICALS, INC. (3)
Acasti Pharma Inc. (1)
ACELRX PHARMACEUTICALS INC (3)
Acer Therapeutics Inc. (2)
ACHILLION PHARMACEUTICALS INC (1)
Adamis Pharmaceuticals Corp (7)
AERIE PHARMACEUTICALS INC (1)
Aerpio Pharmaceuticals, Inc. (2)
AGILE THERAPEUTICS INC (1)
Akers Biosciences, Inc. (3)
Akorn (3)
ALDER BIOPHARMACEUTICALS INC (1)
Alexza Pharmaceuticals Inc. (1)
ALIMERA SCIENCES INC (1)
Allergan, plc (8)
Amag Pharmaceuticals (1)
Amneal Pharmaceuticals, Inc. (6)
Ampio Pharmaceuticals, Inc. (4)
AMYLIN PHARMACEUTICALS INC (1)
Anacor Pharmaceuticals, Inc. (1)
ANADYS PHARMACEUTICALS INC (1)
Angion Biomedica Corp. (1)
ANGIOTECH PHARMACEUTICALS INC (1)
ANI Pharma Inc (8)
APP Pharmaceuticals, Inc. (3)
APRICUS BIOSCIENCES, INC. (5)
ARIAD PHARMACEUTICALS INC (3)
Artemis Therapeutics, Inc. (1)
Assertio Holdings, Inc. (1)
Assertio Therapeutics, Inc (3)
Astex Pharmaceuticals, Inc (1)
Auspex Pharmaceuticals, Inc. (1)
AUXILIUM PHARMACEUTICALS INC (2)
AVADEL PHARMACEUTICALS PLC (1)
AVALON PHARMACEUTICALS INC (3)
AVANIR PHARMACEUTICALS, INC. (1)
AVENUE THERAPEUTICS, INC. (1)
AYTU BIOSCIENCE, INC (5)
BARR PHARMACEUTICALS INC (2)
Baudax Bio, Inc. (1)
Bausch Health Companies Inc. (6)
BENTLEY PHARMACEUTICALS INC (2)
Big Rock Partners Acquisition Corp. (3)
BIODELIVERY SCIENCES INTERNATIONAL INC (2)
BioNumerik Pharmaceuticals, Inc. (3)
BioPharmX Corp (4)
Blue Water Acquisition Corp. (1)
BODY & MIND INC. (1)
Boston Therapeutics, Inc. (6)
Bright Green Corp (3)
Bristol-Myers Squibb (2)
CADENCE PHARMACEUTICALS INC (1)
CALLISTO PHARMACEUTICALS INC (2)
Canbiola, Inc. (2)
Cannabics Pharmaceuticals Inc. (1)
CANNAPHARMARX, INC. (1)
Cantabio Pharmaceuticals Inc. (1)
Cara Therapeutics, Inc. (2)
CARDAX, INC. (5)
Catalent Inc (4)
Celator Pharmaceuticals Inc (1)
CELGENE CORP (5)
Cerecor Inc. (5)
CHIASMA, INC (1)
China Pharmaceuticals Inc (1)
CinCor Pharma, Inc. (1)
Cingulate Inc. (1)
Citius Pharmaceuticals, Inc. (3)
CLS Holdings USA, Inc. (1)
Cocrystal Pharma, Inc. (6)
COLLAGENEX PHARMACEUTICALS INC (1)
COLLEGIUM PHARMACEUTICAL, INC (3)
CoLucid Pharmaceuticals, Inc. (1)
ContraVir Pharmaceuticals, Inc. (4)
COSMO VENTURES INC (1)
CPEX Pharmaceuticals, Inc. (1)
CUBIST PHARMACEUTICALS INC (4)
Cure Pharmaceutical Holding Corp. (2)
CymaBay Therapeutics, Inc. (1)
Dova Pharmaceuticals Inc. (1)
DURECT CORP (1)
DUSA PHARMACEUTICALS INC (1)
Egalet Corp (2)
Elanco Animal Health Inc (3)
ELITE PHARMACEUTICALS INC (1)
Eloxx Pharmaceuticals, Inc. (2)
ENCYSIVE PHARMACEUTICALS INC (1)
Endo International plc (4)
Endo Pharmaceuticals Solutions Inc. (2)
EPIX Pharmaceuticals, Inc. (1)
Evofem Biosciences, Inc. (10)
Exactus, Inc. (1)
EyePoint Pharmaceuticals, Inc. (1)
EYETECH PHARMACEUTICALS INC (1)
FERMAVIR PHARMACEUTICALS, INC. (1)
Foamix Pharmaceuticals Ltd. (2)
FRONTIER OILFIELD SERVICES INC (3)
Furiex Pharmaceuticals, Inc. (1)
GB SCIENCES INC (1)
GENAISSANCE PHARMACEUTICALS INC (2)
GRAYBUG VISION, INC. (2)
GUILFORD PHARMACEUTICALS INC (1)
Harmony Biosciences Holdings, Inc. (1)
HARROW HEALTH, INC. (2)
Horizon Pharma plc (5)
IDENIX PHARMACEUTICALS INC (1)
Ikena Oncology, Inc. (3)
IMAGING3 INC (2)
INNOVATE BIOPHARMACEUTICALS, INC. (4)
Innoviva, Inc. (2)
Innovive Pharmaceuticals, Inc. (1)
INSPIRE PHARMACEUTICALS INC (1)
Intersect ENT, Inc. (1)
Intra-Cellular Therapies, Inc. (2)
ISTA PHARMACEUTICALS INC (2)
Item 9 Labs Corp. (3)
Jaguar Health, Inc. (1)
JAVELIN PHARMACEUTICALS, INC (3)
Jazz Pharmaceuticals plc (5)
Johnson & Johnson (3)
JUNIPER PHARMACEUTICALS INC (1)
Jushi Holdings Inc. (3)
Kala Pharmaceuticals, Inc. (1)
KEMPHARM, INC (2)
KING PHARMACEUTICALS INC (1)
KOS PHARMACEUTICALS INC (1)
Landos Biopharma, Inc. (1)
Lannett Company, Inc. (1)
Lev Pharmaceuticals Inc (1)
Level Brands, Inc. (5)
Lexaria Bioscience Corp. (4)
Lipocine Inc. (1)
Liquidia Corp (2)
Longboard Pharmaceuticals, Inc. (1)
Mallinckrodt (4)
MAP Pharmaceuticals, Inc. (1)
Marijuana Co of America, Inc. (5)
Medicine Man Technologies, Inc. (10)
MEMORY PHARMACEUTICALS CORP (1)
Menlo Therapeutics Inc. (3)
Merck (1)
MICROCHANNEL TECHNOLOGIES CORP (7)
MJ BIOTECH, INC. (1)
MYnd Analytics, Inc. (2)
MyoKardia Inc (1)
Nabriva Therapeutics plc (1)
NEKTAR THERAPEUTICS (1)
Neos Therapeutics, Inc. (1)
Neuralstem, Inc. (1)
NEW RIVER PHARMACEUTICALS INC (1)
NewBridge Global Ventures, Inc. (3)
NGM BIOPHARMACEUTICALS INC (1)
Notis Global, Inc. (2)
NOVEN PHARMACEUTICALS INC (2)
NPS PHARMACEUTICALS INC (2)
NURX PHARMACEUTICALS, INC. (1)
Omthera Pharmaceuticals, Inc. (1)
OncoMed Pharmaceuticals Inc (1)
One World Pharma, Inc. (2)
ONYX PHARMACEUTICALS INC (3)
OPIANT PHARMACEUTICALS, INC. (1)
OPTIMER PHARMACEUTICALS INC (1)
ORAMED PHARMACEUTICALS INC. (2)
OSCIENT PHARMACEUTICALS CORP (1)
OSI PHARMACEUTICALS INC (2)
Pacira Pharmaceuticals, Inc. (2)
Panacea Acquisition Corp (1)
Paratek Pharmaceuticals, Inc. (2)
PEAK PHARMACEUTICALS, INC. (2)
Perrigo (1)
Pfizer (5)
PHARMOS CORP (4)
Phathom Pharmaceuticals, Inc. (1)
Phibro Animal Health Corporation (1)
Phoenix Life Sciences International Limited. (1)
Pivot Pharmaceuticals Inc. (1)
PLAYERS NETWORK (1)
PLx Pharma Inc. (1)
PONIARD PHARMACEUTICALS, INC. (2)
PRAECIS PHARMACEUTICALS INC (1)
Prestige Brands Holdings Inc (1)
Provention Bio, Inc. (1)
Pulmatrix, Inc. (2)
QUANTA INC (2)
QUESTCOR PHARMACEUTICALS INC (1)
Ra Pharmaceuticals, Inc. (1)
Rain Therapeutics Inc. (2)
REATA PHARMACEUTICALS INC (1)
Recro Pharma, Inc. (1)
RELMADA THERAPEUTICS, INC. (1)
RespireRx Pharmaceuticals Inc. (2)
resTORbio, Inc. (1)
Revance Therapeutics, Inc. (4)
Roivant Sciences Ltd. (2)
Sagent Pharmaceuticals, Inc. (2)
SALIX PHARMACEUTICALS LTD (4)
Satsuma Pharmaceuticals, Inc. (2)
SCICLONE PHARMACEUTICALS INC (1)
Semnur Pharmaceuticals, Inc. (2)
SGX PHARMACEUTICALS, INC. (1)
SIGA TECHNOLOGIES INC (1)
Sirtris Pharmaceuticals, Inc. (1)
Somanta Pharmaceuticals Inc. (2)
Sucampo Pharmaceuticals, Inc. (2)
SUNWIN STEVIA INTERNATIONAL, INC. (1)
Supernus Pharmaceuticals, Inc. (2)
SYNERGY PHARMACEUTICALS, INC. (3)
Synovics Pharmaceuticals (1)
Target Group Inc. (1)
Targeted Medical Pharma, Inc. (2)
TAURIGA SCIENCES, INC. (5)
Tenzing Acquisition Corp. (1)
Terra Tech Corp. (13)
TETRALOGIC PHARMACEUTICALS CORP (1)
TETRAPHASE PHARMACEUTICALS INC (7)
Textmunication Holdings, Inc. (2)
The Medicines Company (4)
TherapeuticsMD, Inc. (4)
Theseus Pharmaceuticals, Inc. (1)
Tilray, Inc. (1)
TITAN PHARMACEUTICALS INC (2)
Tribute Pharmaceuticals Canada Inc. (2)
Trubion Pharmaceuticals, Inc (1)
Trulieve Cannabis Corp. (1)
Urigen Pharmaceuticals, Inc. (4)
Urovant Sciences Ltd. (1)
VALEANT PHARMACEUTICALS INTERNATIONAL (3)
Valera Pharmaceuticals Inc (1)
Vallon Pharmaceuticals, Inc. (1)
VIA Pharmaceuticals, Inc. (2)
VICURON PHARMACEUTICALS INC (1)
VioQuest Pharmaceuticals, Inc. (2)
Vireo Health International, Inc. (3)
Vitae Pharmaceuticals, Inc (1)
Vitality Biopharma, Inc. (2)
Winston Pharmaceuticals, Inc. (3)
ZOGENIX, INC. (7)
Zynerba Pharmaceuticals, Inc. (2)

Recent Contracts

Agreement and Plan of Merger, dated as of December 18, 2024, by and among Vireo WH Merger Sub Inc., Vireo Growth Inc., WholesomeCo, Inc. and Shareholder Representative Services LLC (Vireo Health International, Inc., Filed With SEC on December 23, 2024)
Agreement and Plan of Merger, dated as of December 18, 2024, by and among Vireo PR Merger Sub Inc., Vireo PR Merger Sub II Inc., Vireo Growth Inc., NGH Investments, Inc., Proper... (Vireo Health International, Inc., Filed With SEC on December 23, 2024)
Agreement and Plan of Merger, dated as of December 18, 2024, by and among Vireo DR Merger Sub Inc., Vireo Growth Inc., Deep Roots Holdings, Inc. and Shareholder Representative... (Vireo Health International, Inc., Filed With SEC on December 23, 2024)
Agreement and Plan of Merger and Reorganization, dated December 17, 2024, by and among Cara Therapeutics, Inc., CT Convergence Merger Sub, Inc. and Tvardi Therapeutics, Inc (Cara Therapeutics, Inc., Filed With SEC on December 18, 2024)
Amendment to the Amended and Restated Agreement and Plan of Merger, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and Revance Therapeutics, Inc. dated as of... (Revance Therapeutics, Inc., Filed With SEC on December 12, 2024)
Termination Agreement, dated as of December 10, 2024 by and between Hepion Pharmaceuticals, Inc., Pharma Two B Ltd. and Pearl Merger Sub, Inc (ContraVir Pharmaceuticals, Inc., Filed With SEC on December 11, 2024)
Amended and Restated Support Agreement, dated as of December 7, 2024, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and the parties named on Schedule A thereto... (Revance Therapeutics, Inc., Filed With SEC on December 9, 2024)
Amended and Restated Agreement and Plan of Merger, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and Revance Therapeutics, Inc. dated as of December 7, 2024 (Revance Therapeutics, Inc., Filed With SEC on December 9, 2024)
Fourth Amendment to the Amended and Restated Agreement and Plan of Merger, by and among the Company, Aditxt, Inc. and Adifem, Inc., dated November 19, 2024 (Evofem Biosciences, Inc., Filed With SEC on November 25, 2024)
Agreement and Plan of Merger and Reorganization, dated as of November 13, 2024, by and among Pulmatrix, Inc., PCL Merger Sub, Inc., PCL Merger Sub II, LLC and Cullgen Inc (Pulmatrix, Inc., Filed With SEC on November 13, 2024)
Amendment No. 1 to Agreement and Plan of Merger, dated as of August 7, 2019, by and among Semnur Pharmaceuticals, Inc., Scilex Holding Company, Sigma Merger Sub, Inc., Fortis... (Semnur Pharmaceuticals, Inc., Filed With SEC on November 6, 2024)
Agreement and Plan of Merger, dated as of March 18, 2019, by and among Scilex Holding Company, Sigma Merger Sub, Inc., Semnur Pharmaceuticals, Inc., Fortis Advisors LLC, solely as... (Semnur Pharmaceuticals, Inc., Filed With SEC on November 6, 2024)
Agreement and Plan of Merger, dated October 23, 2024, by and among Can B Corp., Nascent Pharma Holdings, Inc. and Nascent Merger Sub (Canbiola, Inc., Filed With SEC on October 28, 2024)
Agreement and Plan of Merger, dated as of October 14, 2024, by and among Longboard Pharmaceuticals, Inc., H. Lundbeck A/S, Langkawi Corporation and Lundbeck LLC (Longboard Pharmaceuticals, Inc., Filed With SEC on October 15, 2024)
Third Amendment to the Amended and Restated Agreement and Plan of Merger, by and among the Company, Aditxt, Inc. and Adifem, Inc., dated October 2, 2024 (Evofem Biosciences, Inc., Filed With SEC on October 3, 2024)
Second Amendment to the Amended and Restated Agreement and Plan of Merger, by and among the Company, Aditxt, Inc. and Adifem, Inc., dated September 6, 2024 (Evofem Biosciences, Inc., Filed With SEC on September 6, 2024)
First Amendment to the Amended and Restated Agreement and Plan of Merger, by and among the Company, Aditxt, Inc. and Adifem, Inc., dated August 16, 2024 (Evofem Biosciences, Inc., Filed With SEC on August 20, 2024)
Merger and Contribution and Share Exchange Agreement, dated as of August 19, 2024, by and among Titan Pharmaceuticals, Inc., TTNP Merger Sub, Inc., KE Sdn. Bhd., and BSKE Ltd (TITAN PHARMACEUTICALS INC, Filed With SEC on August 19, 2024)
Side Letter Agreement, dated August 12, 2024, by and by and among Citius Pharmaceuticals, Inc., Citius Oncology, Inc., TenX Keane Acquisition and TenX Merger Sub, Inc (Citius Pharmaceuticals, Inc., Filed With SEC on August 16, 2024)
Agreement and Plan of Merger, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and Revance Therapeutics, Inc. dated as of August 11, 2024 (Revance Therapeutics, Inc., Filed With SEC on August 12, 2024)
Agreement and Plan of Merger, dated as of July 28, 2024, by and among the Company, Ironshore Therapeutics Inc. and Shareholder Representative Services LLC (COLLEGIUM PHARMACEUTICAL, INC, Filed With SEC on July 29, 2024)
Agreement and Plan of Merger, dated as of July 19, 2024, by and among the Company, Parent and Merger Sub (ContraVir Pharmaceuticals, Inc., Filed With SEC on July 22, 2024)
Amended and Restated Plan of Merger, by and between the Company, Aditxt, Inc. and Adifem, Inc (Evofem Biosciences, Inc., Filed With SEC on July 18, 2024)
Agreement and Plan of Merger, dated June 25, 2024, by and among Insud Pharma, S.L., Exeltis Project, Inc. and the Company (AGILE THERAPEUTICS INC, Filed With SEC on June 26, 2024)
Agreement and Plan of Merger (ALIMERA SCIENCES INC, Filed With SEC on June 24, 2024)
Agreement and Plan of Merger dated June 21, 2024, by and among ANI Pharmaceuticals, Inc., ANIP Merger Sub INC. and Alimera Sciences, Inc (ANI Pharma Inc, Filed With SEC on June 24, 2024)
Fourth Amendment to the Agreement and Plan of Merger dated as of May 2, 2024, by and among Aditxt, Inc., Adifem, Inc. and Evofem Biosciences, Inc (Evofem Biosciences, Inc., Filed With SEC on May 2, 2024)
Agreement and Plan of Merger and Reorganization, dated March (Cerecor Inc., Filed With SEC on March 28, 2024)
Agreement and Plan of Merger and Reorganization, dated March 24, 2024, by and among Nuvation Bio Inc., AnHeart Therapeutics Ltd., Artemis Merger Sub I, Ltd. and Artemis Merger Sub... (Panacea Acquisition Corp, Filed With SEC on March 25, 2024)
Agreement and Plan of Merger, dated as of March 24, 2024, by and among Landos Biopharma, Inc., AbbVie Inc., Bespin Subsidiary, LLC and Bespin Merger Sub, Inc (Landos Biopharma, Inc., Filed With SEC on March 25, 2024)
Agreement and Plan of Merger, dated March 4, 2024, by and between MyMD Pharmaceuticals, Inc., a New Jersey corporation, and MyMD Pharmaceuticals, Inc., a Delaware corporation (Akers Biosciences, Inc., Filed With SEC on March 7, 2024)
Third Amendment to Agreement and Plan of Merger dated as of February 29, 2024, by and among Aditxt, Inc., Adicure, Inc. and Evofem Biosciences, Inc (Evofem Biosciences, Inc., Filed With SEC on March 6, 2024)
Agreement and Plan of Merger, dated as of February 28, 2024, by and among Societal CDMO, Inc., CoreRx, Inc. and Cane Merger Sub, Inc (Recro Pharma, Inc., Filed With SEC on February 28, 2024)
Agreement and Plan of Merger, dated February 25, 2024, by and among NGM Biopharmaceuticals, Inc., Atlas Neon Parent, Inc. and Atlas Neon Merger Sub, Inc (NGM BIOPHARMACEUTICALS INC, Filed With SEC on February 26, 2024)
Agreement and Plan of Merger, dated as of February 11, 2024, by and among CymaBay Therapeutics, Inc., Gilead Sciences, Inc. and Pacific Merger Sub, Inc (CymaBay Therapeutics, Inc., Filed With SEC on February 12, 2024)
Agreement and Plan of Merger, dated as of February 5, 2024, by and among the Company, Parent and Merger Sub (Catalent Inc, Filed With SEC on February 5, 2024)
Second Amendment to the Merger Agreement, dated January 30, 2024 (Evofem Biosciences, Inc., Filed With SEC on January 31, 2024)
Contingent Value Rights Agreement, dates January 26, 2024, by and among Parent, Merger Sub, Equiniti Trust Company, LLC and Fortis Advisors LLC (Rain Therapeutics Inc., Filed With SEC on January 26, 2024)
Joint Venture Agreement, dated January 22, 2024, among Oramed Pharmaceuticals Inc., Oramed Ltd., Hefei Tianhui Biotech Co., Ltd. and Technowl Limited (ORAMED PHARMACEUTICALS INC., Filed With SEC on January 23, 2024)
First Amendment to the Merger Agreement, dated January 8, 2024 (Evofem Biosciences, Inc., Filed With SEC on January 11, 2024)